Who did the American College of Physicians recommend an RSV vaccine for?

The American College of Physicians developed these rapid practice points from a rapid review of RSV vaccine efficacy, comparative effectiveness, and harms. Although the review's starting population was adults aged 18 or older who are not pregnant or immunocompromised, the practice points themselves apply to adults aged 60 or older who are not immunocompromised.

The two age-based practice points

Adults aged 75 years or older should receive a protein subunit RSV vaccine. Adults aged 60 to 74 years who are at increased risk for severe RSV may consider receiving a protein subunit RSV vaccine.

The first sentence is a recommendation; the second is a choice tied to individual risk. For adults aged 60 to 74 years, the option is conditional on being at increased risk for severe RSV, whereas no additional risk condition is stated for the 75-plus group.

The available abstract does not list what makes someone in the 60-to-74 age band at increased risk for severe RSV; those criteria would need to come from the fuller guidance. The practice points do not apply to people younger than 60, pregnant people, or people who are immunocompromised.